Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes: A systematic review

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

Standard

Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes : A systematic review. / Rasmussen, Vinni Faber; Jensen, Troels Staehelin; Tankisi, Hatice; Karlsson, Páll; Vestergaard, Esben Thyssen; Kristensen, Kurt; Nyengaard, Jens Randel; Terkelsen, Astrid Juhl.

In: Journal of Diabetes and its Complications, Vol. 35, No. 11, 108027, 11.2021.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{446a596fc2ae4b63a12f0c53b7ff4873,
title = "Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes: A systematic review",
abstract = "AIMS: To estimate the prevalence of neuropathy in adolescents with type 1 diabetes.METHODS: Systematic collection of published studies exploring the prevalence of large fibre neuropathy (LFN), small fibre neuropathy (SFN), and autonomic neuropathy in adolescents with type 1 diabetes. Following prospective registration (Prospero CRD42020206093), PubMed, EMBASE, and Cochrane Library were searched for studies from 2000 to 2020. PICO framework was used in the selection process (Population: adolescents aged 10-19 years with type 1 diabetes; Intervention: diagnostic methods for neuropathy; Comparison: reference data; Outcome: data on prevalence or comparison). Data were extracted concerning study quality based on available data and established methods for determining and diagnosing various neuropathy types.RESULTS: From 2,017 initial citations, 27 studies (7589 participants) fulfilled eligibility criteria. The study population (47% males) had a diabetes duration between 4.0 and 10.6 years, and HbA1c level between 7.3 and 10.8%, 56-95 mmol/mol. The prevalence of LFN, based on nerve conduction studies, was 10-57%. Based on other tests for neuropathy, the prevalence of LFN and SFN was 12-62%, and that of cardiac autonomic neuropathy was 12-75%.CONCLUSION: The described prevalence of neuropathy in adolescents with type 1 diabetes varied, which can be methodological due to different screening methods and classifications of neuropathy.",
author = "Rasmussen, {Vinni Faber} and Jensen, {Troels Staehelin} and Hatice Tankisi and P{\'a}ll Karlsson and Vestergaard, {Esben Thyssen} and Kurt Kristensen and Nyengaard, {Jens Randel} and Terkelsen, {Astrid Juhl}",
note = "Copyright {\textcopyright} 2021 The Authors. Published by Elsevier Inc. All rights reserved.",
year = "2021",
month = nov,
doi = "10.1016/j.jdiacomp.2021.108027",
language = "English",
volume = "35",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier Inc.",
number = "11",

}

RIS

TY - JOUR

T1 - Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes

T2 - A systematic review

AU - Rasmussen, Vinni Faber

AU - Jensen, Troels Staehelin

AU - Tankisi, Hatice

AU - Karlsson, Páll

AU - Vestergaard, Esben Thyssen

AU - Kristensen, Kurt

AU - Nyengaard, Jens Randel

AU - Terkelsen, Astrid Juhl

N1 - Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

PY - 2021/11

Y1 - 2021/11

N2 - AIMS: To estimate the prevalence of neuropathy in adolescents with type 1 diabetes.METHODS: Systematic collection of published studies exploring the prevalence of large fibre neuropathy (LFN), small fibre neuropathy (SFN), and autonomic neuropathy in adolescents with type 1 diabetes. Following prospective registration (Prospero CRD42020206093), PubMed, EMBASE, and Cochrane Library were searched for studies from 2000 to 2020. PICO framework was used in the selection process (Population: adolescents aged 10-19 years with type 1 diabetes; Intervention: diagnostic methods for neuropathy; Comparison: reference data; Outcome: data on prevalence or comparison). Data were extracted concerning study quality based on available data and established methods for determining and diagnosing various neuropathy types.RESULTS: From 2,017 initial citations, 27 studies (7589 participants) fulfilled eligibility criteria. The study population (47% males) had a diabetes duration between 4.0 and 10.6 years, and HbA1c level between 7.3 and 10.8%, 56-95 mmol/mol. The prevalence of LFN, based on nerve conduction studies, was 10-57%. Based on other tests for neuropathy, the prevalence of LFN and SFN was 12-62%, and that of cardiac autonomic neuropathy was 12-75%.CONCLUSION: The described prevalence of neuropathy in adolescents with type 1 diabetes varied, which can be methodological due to different screening methods and classifications of neuropathy.

AB - AIMS: To estimate the prevalence of neuropathy in adolescents with type 1 diabetes.METHODS: Systematic collection of published studies exploring the prevalence of large fibre neuropathy (LFN), small fibre neuropathy (SFN), and autonomic neuropathy in adolescents with type 1 diabetes. Following prospective registration (Prospero CRD42020206093), PubMed, EMBASE, and Cochrane Library were searched for studies from 2000 to 2020. PICO framework was used in the selection process (Population: adolescents aged 10-19 years with type 1 diabetes; Intervention: diagnostic methods for neuropathy; Comparison: reference data; Outcome: data on prevalence or comparison). Data were extracted concerning study quality based on available data and established methods for determining and diagnosing various neuropathy types.RESULTS: From 2,017 initial citations, 27 studies (7589 participants) fulfilled eligibility criteria. The study population (47% males) had a diabetes duration between 4.0 and 10.6 years, and HbA1c level between 7.3 and 10.8%, 56-95 mmol/mol. The prevalence of LFN, based on nerve conduction studies, was 10-57%. Based on other tests for neuropathy, the prevalence of LFN and SFN was 12-62%, and that of cardiac autonomic neuropathy was 12-75%.CONCLUSION: The described prevalence of neuropathy in adolescents with type 1 diabetes varied, which can be methodological due to different screening methods and classifications of neuropathy.

U2 - 10.1016/j.jdiacomp.2021.108027

DO - 10.1016/j.jdiacomp.2021.108027

M3 - Review

C2 - 34429229

VL - 35

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 11

M1 - 108027

ER -